ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MOUSSA FAMININI MD

Endocrinology, Diabetes Metabolism

32,302

$2.23M

962
900 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 45%

$69
Average prescription price

Avg: $111

LAN NGUYEN MD

Endocrinology, Diabetes Metabolism

30,590

$2.96M

576
501 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

55%
prescriptions for brand name drugs

Avg: 45%

$97
Average prescription price

Avg: $111

SAMUEL MALAYAN

Endocrinology, Diabetes Metabolism

26,348

$3.04M

540
446 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 45%

$115
Average prescription price

Avg: $111

CHAU LE MD

Endocrinology, Diabetes Metabolism

23,219

$1.21M

587
521 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 45%

$52
Average prescription price

Avg: $111

IRINA URUSOVA MD

Endocrinology, Diabetes Metabolism

21,611

$2.4M

906
820 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

63%
prescriptions for brand name drugs

Avg: 45%

$111
Average prescription price

Avg: $111

GEORGE YANG M.D.

Endocrinology, Diabetes Metabolism

21,241

$1.44M

574
504 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 3%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 45%

$68
Average prescription price

Avg: $111

GEORGE CHAO MD

Endocrinology, Diabetes Metabolism

19,669

$2.6M

982
748 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 45%

$132
Average prescription price

Avg: $111

JUAN CALDERON M.D.

Endocrinology, Diabetes Metabolism

17,124

$1.4M

586
496 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 45%

$82
Average prescription price

Avg: $111

CHARLES HOLZNER M.D.

Endocrinology, Diabetes Metabolism

16,009

$781K

982
744 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 45%

$49
Average prescription price

Avg: $111

NICHOLAS TRAN M.D.

Endocrinology, Diabetes Metabolism

15,346

$1.66M

440
385 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 45%

$108
Average prescription price

Avg: $111

ZDZISLAUS WANSKI MD

Endocrinology, Diabetes Metabolism

14,987

$1.03M

882
663 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 45%

$68
Average prescription price

Avg: $111

RAYMOND FINK M.D.

Endocrinology, Diabetes Metabolism

13,895

$1.76M

1026
807 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 45%

$127
Average prescription price

Avg: $111

ATIF ALAZIZ M.D.

Endocrinology, Diabetes Metabolism

13,885

$1.04M

723
650 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 3%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 45%

$75
Average prescription price

Avg: $111

HUGH NASR MD

Endocrinology, Diabetes Metabolism

13,091

$890K

759
673 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

11%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 45%

$68
Average prescription price

Avg: $111

JEFFREY BODWIN MD

Endocrinology, Diabetes Metabolism

13,007

$1.38M

640
546 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 45%

$106
Average prescription price

Avg: $111

JEAN PARTAMIAN M.D

Endocrinology, Diabetes Metabolism

12,774

$1.04M

331
303 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 45%

$81
Average prescription price

Avg: $111

BARBARA LEBRON M.D.

Endocrinology, Diabetes Metabolism

12,271

$581K

590
508 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

16%
patients receiving schedule three controlled substances

Avg: 3%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 45%

$47
Average prescription price

Avg: $111

MARK KLEBANOV M.D.

Endocrinology, Diabetes Metabolism

11,604

$913K

439
418 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 45%

$79
Average prescription price

Avg: $111

JOSELITO CABACCAN M.D.

Endocrinology, Diabetes Metabolism

10,558

$1.66M

779
661 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 45%

$158
Average prescription price

Avg: $111

MICHAEL LIN MD

Endocrinology, Diabetes Metabolism

9,647

$1.57M

730
619 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

54%
prescriptions for brand name drugs

Avg: 45%

$163
Average prescription price

Avg: $111

KIN-KEE PUN M.D.

Endocrinology, Diabetes Metabolism

9,265

$980K

1047
1000 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 45%

$106
Average prescription price

Avg: $111

JEFFREY SANDLER M.D.

Endocrinology, Diabetes Metabolism

9,213

$1.09M

741
565 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 3%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 45%

$118
Average prescription price

Avg: $111

STEVEN SALTMAN M.D.

Endocrinology, Diabetes Metabolism

8,969

$787K

482
438 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 45%

$88
Average prescription price

Avg: $111

ANGELITA BEREDO M.D.

Endocrinology, Diabetes Metabolism

8,833

$863K

325
256 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 45%

$98
Average prescription price

Avg: $111

JOHN GILBERT M.D.

Endocrinology, Diabetes Metabolism

8,793

$898K

743
662 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 45%

$102
Average prescription price

Avg: $111

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank